![]() |
市場調查報告書
商品編碼
1520409
2024-2032 年按產品、動物類型、給藥途徑、配銷通路和地區分類的獸醫市場報告Veterinary Medicine Market Report by Product, Animal Type, Route of Administration, Distribution Channel, and Region 2024-2032 |
2023年全球獸藥市場規模達354億IMARC Group。寵物擁有量的增加、診斷和治療方面的重大技術進步、對牲畜食品安全和疾病控制的需求不斷成長、政府促進動物健康的舉措、該領域持續的研究和開發以及生產動物和伴侶動物對獸醫護理的需求是推動市場的一些主要因素。
獸醫學是醫學的一個專業分支,專注於動物的健康和福祉。它包括各種動物物種疾病、損傷和病症的診斷、治療和預防。它在促進動物健康、福利和公共衛生方面發揮著至關重要的作用。獸醫是經過獸醫訓練的專業人員,負責為動物(包括家養寵物、牲畜、野生動物和實驗動物)提供醫療照護。他們進行徹底檢查、進行診斷測試、開藥、進行手術並提供疫苗接種等預防性護理。獸醫領域涵蓋多個學科,包括內科、外科、皮膚科、放射科、病理學和牙科。獸醫與寵物主人、畜牧養殖者、動物園管理員和動物行業的其他專業人員密切合作,以確保他們照顧的動物的福祉。
養寵物的趨勢不斷上升,特別是在城市地區,正在推動獸藥的需求。寵物主人擴大尋求獸醫服務來滿足常規檢查、疫苗接種和醫療保健需求,從而推動了市場的成長。此外,人們更加重視動物福利和預防保健,從而提高了人們對動物醫學重要性的認知。寵物主人和畜牧養殖者正在認知到定期獸醫檢查對於確保動物整體健康和福祉的重要性。除此之外,可以從動物傳播給人類的人畜共通傳染病近年來引起了廣泛關注。此外,禽流感和 COVID-19 等疾病的爆發凸顯了對有效獸醫學來預防和控制此類疾病的需求,從而導致對動物健康的投資增加。除此之外,對肉類、乳製品和其他動物性食品的需求不斷成長,增加了畜牧生產中對獸藥的需求。確保農場動物的健康和福祉對於維持食品安全標準和滿足不斷成長的消費者需求至關重要。除此之外,診斷影像、實驗室檢測和外科技術等獸醫技術的進步顯著改善了動物疾病的診斷和治療。此外,針對動物健康和福利的政府法規和措施在塑造市場方面發揮著至關重要的作用。
增加寵物擁有量
養寵物的成長趨勢是市場的重要動力。隨著越來越多的人選擇養寵物,對獸醫服務的需求也隨之上升。寵物主人越來越意識到定期獸醫護理的重要性,以確保毛茸茸的同伴的健康和福祉。他們尋求預防措施,例如接種疫苗、定期檢查以及針對跳蚤、蜱蟲和牙齒問題等常見疾病的治療。對獸醫服務不斷成長的需求為專門從事獸醫醫學的診所、醫院和製藥公司創造了機會。此外,寵物主人與其動物之間的情感紐帶推動了對其醫療保健的投資意願,從而導致市場進一步成長。
技術進步
技術進步徹底改變了獸醫醫學領域,推動了市場成長。數位放射成像和超音波等診斷成像的創新可以實現更準確、更及時的診斷。先進的實驗室檢測方法可以更快、更準確地識別疾病。包括微創手術和雷射手術在內的外科技術改善了患者的治療效果並縮短了復原時間。這些技術進步不僅提高了護理質量,還增加了對獸醫服務的需求。採用這些技術的獸醫實踐獲得了競爭優勢,並吸引了更多尋求最先進的動物護理的客戶群。
畜牧業生產及食品安全
確保動物健康、福利和食品安全的需求推動了畜牧生產中獸藥的需求。隨著全球人口的增加和肉類消費的增加,畜牧農民面臨滿足動物性食品需求的挑戰。它在維持牲畜的健康和生產力方面發揮著至關重要的作用。定期的獸醫護理、疾病預防計劃和適當的管理實踐有助於提高產品品質並降低食源性疾病的風險。消費者對食品安全和動物道德對待的擔憂進一步強調了畜牧業對強力的獸醫保健的需求。因此,對獸醫和動物健康管理的投資持續成長,支持了市場的擴張。
The global veterinary medicine market size reached US$ 35.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 59.1 Billion by 2032, exhibiting a growth rate (CAGR) of 5.7% during 2024-2032. The increasing pet ownership, significant technological advancements in diagnostics and treatments, rising need for food safety and disease control in livestock, government initiatives promoting animal health, and ongoing research and development in the field and the demand for veterinary care in both production and companion animals are some of the major factors propelling the market.
Veterinary medicine is a specialized branch of medical science that focuses on the health and well-being of animals. It encompasses the diagnosis, treatment, and prevention of diseases, injuries, and disorders in various animal species. It plays a crucial role in promoting animal health, welfare, and public health. Veterinarians, trained professionals in veterinary medicine, are responsible for providing medical care to animals, including domestic pets, livestock, wildlife, and laboratory animals. They conduct thorough examinations, perform diagnostic tests, prescribe medications, perform surgeries, and provide preventive care such as vaccinations. The field of veterinary medicine encompasses various disciplines, including internal medicine, surgery, dermatology, radiology, pathology, and dentistry. Veterinarians work closely with pet owners, livestock farmers, zookeepers, and other professionals in the animal industry to ensure the well-being of animals under their care.
The rising trend of pet ownership, particularly in urban areas, is driving the demand for veterinary medicine. Pet owners are increasingly seeking veterinary services for routine check-ups, vaccinations, and healthcare needs, thus fueling the growth of the market. Additionally, there is a greater emphasis on animal welfare and preventive care, leading to increased awareness regarding the importance of medicine for animals. Pet owners and livestock farmers are recognizing the significance of regular veterinary visits to ensure the overall health and well-being of their animals. Other than this, zoonotic diseases, which can be transmitted from animals to humans, have gained significant attention in recent years. Furthermore, the outbreak of diseases like avian influenza and COVID-19 have highlighted the need for effective veterinary medicine to prevent and control such diseases, leading to increased investments in animal health. Besides this, the growing demand for meat, dairy products, and other animal-derived food products has increased the need for veterinary medicine in livestock production. Ensuring the health and well-being of farm animals is crucial for maintaining food safety standards and meeting the rising consumer demand. Besides this, advancements in veterinary technology, such as diagnostic imaging, laboratory testing, and surgical techniques, have significantly improved the diagnosis and treatment of animal diseases. Moreover, government regulations and initiatives aimed at animal health and welfare play a vital role in shaping the market.
Increasing pet ownership
The increasing trend of pet ownership is a significant driver of the market. As more people choose to have pets, the demand for veterinary services rises accordingly. Pet owners are increasingly aware of the importance of regular veterinary care to ensure the health and well-being of their furry companions. They seek preventive measures such as vaccinations, regular check-ups, and treatments for common conditions like fleas, ticks, and dental problems. This growing demand for veterinary services creates opportunities for clinics, hospitals, and pharmaceutical companies specializing in veterinary medicine. Additionally, the emotional bond between pet owners and their animals drives the willingness to invest in their healthcare, leading to further market growth.
Technological advancements
Technological advancements have revolutionized the field of veterinary medicine, driving market growth. Innovations in diagnostic imaging, such as digital radiography and ultrasound, enable more accurate and timely diagnoses. Advanced laboratory testing methods allow for quicker and more precise identification of diseases. Surgical techniques, including minimally invasive procedures and laser surgery, have improved patient outcomes and reduced recovery times. These technological advancements not only enhance the quality of care but also increase the demand for veterinary services. Veterinary practices that adopt these technologies gain a competitive edge and attract a larger client base seeking state-of-the-art care for their animals.
Livestock production and food safety
The demand for veterinary medicine in livestock production is driven by the need to ensure animal health, welfare, and food safety. With the increasing global population and rising meat consumption, livestock farmers face the challenge of meeting the demand for animal-derived food products. It plays a crucial role in maintaining the health and productivity of livestock. Regular veterinary care, disease prevention programs, and proper management practices contribute to higher-quality products and reduce the risk of foodborne illnesses. Consumer concerns regarding food safety and the ethical treatment of animals further emphasize the need for robust veterinary healthcare in the livestock industry. As a result, investments in veterinary medicine and animal health management continue to grow, supporting the expansion of the market.
IMARC Group provides an analysis of the key trends in each segment of the global veterinary medicine market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product, animal type, route of administration and distribution channel.
Drugs
Anti-infective
Anti-inflammatory
Parasiticide
Vaccines
Inactivated Vaccines
Attenuated Vaccines
Recombinant Vaccines
Medicated Feed Additives
Amino Acids
Antibiotics
The report has provided a detailed breakup and analysis of the market based on the product. This includes drugs (anti-infective, anti-inflammatory, and parasiticide), vaccines (inactivated vaccines, attenuated vaccines, recombinant vaccines), and medicated feed additives (amino acids and antibiotics).
Drugs play a crucial role in the treatment and management of animal diseases and conditions. Veterinary drugs include a wide range of pharmaceutical products such as antibiotics, anti-inflammatory drugs, antiparasitics, analgesics, and hormonal therapies. These drugs are specifically formulated and approved for use in animals to address various health issues. The market for veterinary drugs is driven by the need for effective treatment options, advancements in drug development, and the growing prevalence of animal diseases.
Vaccines stimulate an immune response in animals, providing protection against specific diseases. Veterinary vaccines help prevent the spread of infectious diseases and reduce the severity of outbreaks in animals. They are used in both companion animals and livestock, contributing to the overall health and well-being of the animal population. The demand for veterinary vaccines is driven by increased awareness of preventive healthcare, government regulations promoting vaccination programs, and the focus on disease control in animal populations.
Medicated feed additives are substances added to animal feed to deliver specific medications or nutritional supplements. These additives can contain drugs, vitamins, minerals, or other bioactive compounds to improve animal health, enhance growth performance, or prevent and control diseases. Medicated feed additives are commonly used in livestock production, where they contribute to optimized feed efficiency, disease prevention, and overall animal well-being. The market for medicated feed additives is driven by the demand for improved feed quality, the need for efficient disease prevention in large-scale farming, and the emphasis on maximizing productivity in the livestock industry.
Production
Companion
Production holds the largest share in the market
A detailed breakup and analysis of the market based on the animal type has also been provided in the report. This includes production and companion. According to the report, production accounted for the largest market share.
The market for production animals encompasses livestock and poultry, including cattle, swine, poultry, sheep, and fish. These animals are primarily raised for meat, milk, eggs, and other animal-derived products. The veterinary care for production animals focuses on disease prevention, herd health management, reproductive health, and nutrition. The market for production animals is driven by the increasing global demand for animal protein, advancements in livestock farming practices, the need to ensure food safety, and the emphasis on sustainable and efficient production methods.
The market for companion animals includes domestic pets such as dogs, cats, and exotic pets like birds, reptiles, and small mammals. Companion animal care encompasses a wide range of veterinary services, including preventive care, vaccinations, routine check-ups, dental care, and treatment for various health conditions. The market for companion animals is driven by the growing pet ownership trends, increased awareness of pet health and well-being, the emotional bond between pet owners and their animals, and the demand for high-quality veterinary care, diagnostics, medications, and pet products. The focus on pet health and the willingness to invest in their care contribute to the growth of this segment of the market.
Oral
Parenteral
Topical
Parenteral dominates the market
The report has provided a detailed breakup and analysis of the market based on the administration. This includes oral, parenteral, and topical. According to the report, parenteral represented the largest segment.
Oral administration refers to the delivery of veterinary medications or treatments through the oral route, typically in the form of tablets, capsules, liquids, or feed additives. Oral administration is commonly used in veterinary medicine due to its convenience and ease of use. It allows for controlled dosing, long-lasting effects, and can be administered directly by the animal owner or mixed with food. The market for oral administration products in veterinary medicine is driven by the wide range of oral medications available, the preference for non-invasive administration methods, and the need for medications that can be easily administered to animals at home or on farms.
Parenteral administration involves the delivery of veterinary medications or treatments through routes other than the digestive tract, such as injections (intravenous, intramuscular, subcutaneous), infusions, or implantations. Parenteral administration allows for rapid absorption and immediate effect, making it suitable for emergencies, critical conditions, or situations where precise dosing is required. The market for parenteral administration products in veterinary medicine is driven by the need for fast-acting medications, the ability to administer drugs in a controlled and accurate manner, and the demand for injectable vaccines, antibiotics, anesthetics, and other treatments in both production and companion animals.
Topical administration involves the application of veterinary medications or treatments directly to the skin or mucous membranes of animals. This can include ointments, creams, sprays, powders, or spot-on treatments. Topical administration is commonly used for localized treatment of skin conditions, external parasites, wound care, or eye and ear ailments. It offers localized therapeutic effects, ease of application, and reduced systemic side effects. The market for topical administration products in veterinary medicine is driven by the demand for dermatological treatments, flea and tick control products, wound management solutions, and other topical medications for both companion and production animals.
Veterinary Hospitals and Clinics
Point-of-Care Testing/In-house Testing
Others
Veterinary hospitals and clinics represent the largest distribution channel
A detailed breakup and analysis of the market based on the distribution channel has also been provided in the report. This includes veterinary hospitals and clinics, point-of-care testing/in-house testing, and others. According to the report, veterinary hospitals and clinics accounted for the largest market share.
Veterinary hospitals and clinics serve as primary points of care for animals, providing a wide range of veterinary services, including examinations, diagnostics, treatments, surgeries, and preventive care. They have well-equipped laboratories, pharmacy services, and access to a variety of veterinary medications and products. Veterinary hospitals and clinics play a vital role in the distribution of prescription medications, specialized diets, and other veterinary products. They often have established relationships with pharmaceutical companies and distributors to ensure the availability of a diverse range of veterinary medications and supplies.
Point-of-care testing, also known as in-house testing, refers to diagnostic tests conducted on-site at veterinary clinics or hospitals. These tests allow for rapid and immediate results, enabling veterinarians to make timely treatment decisions. Point-of-care testing encompasses various diagnostic methods, including blood tests, urine tests, imaging technologies, and molecular diagnostics. The market for point-of-care testing is driven by the increasing demand for quick and accurate diagnoses, convenience, and the ability to provide immediate care to animals. Veterinary clinics and hospitals invest in point-of-care testing equipment and kits to enhance their diagnostic capabilities and offer comprehensive veterinary services in a timely manner.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance in the market
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for veterinary medicines.
North America comprises the United States and Canada, which have well-established veterinary healthcare systems and a large population of both companion and production animals. The market in North America is driven by factors such as the increasing pet ownership, rising demand for quality animal healthcare, advancements in veterinary technology, and a strong focus on animal welfare. The region has a well-developed network of veterinary hospitals, clinics, and specialized veterinary care providers. Additionally, there is significant investment in research and development, leading to the introduction of new veterinary drugs, vaccines, and diagnostic tools. North America also has stringent regulations regarding animal health and welfare, driving the demand for veterinary products and services.
Europe represents a substantial market for veterinary medicine, encompassing countries such as the United Kingdom, Germany, France, and Italy. The market in Europe is driven by factors such as a large population of companion animals, a strong focus on preventive healthcare, stringent regulatory standards, and a high level of pet ownership. European countries have well-established veterinary healthcare systems, with a wide network of veterinary clinics, hospitals, and specialized centers. The region emphasizes the importance of vaccination programs, disease control, and public health concerns related to zoonotic diseases. Additionally, Europe is witnessing advancements in veterinary technology, research collaborations, and investments in innovative treatment modalities, further driving the market growth.
The Asia Pacific region represents a rapidly growing market for veterinary medicine. The region comprises countries such as China, Japan, India, Australia, and emerging economies in Southeast Asia. The market in Asia Pacific is driven by factors such as the increasing disposable income, urbanization, rising pet ownership, and growing demand for animal-derived food products. Asia Pacific has a large population of both companion and production animals, contributing to the demand for veterinary services. The region also witnesses the rising adoption of Western veterinary practices and an increasing focus on animal welfare and preventive healthcare. With the expansion of the middle class and the evolving livestock industry, there is a growing need for advanced veterinary products, diagnostic tools, vaccines, and medications. The market in Asia Pacific is supported by investments in veterinary infrastructure, research and development, and government initiatives promoting animal health and welfare.
Key players invest significantly in research and development to innovate and introduce new veterinary drugs, vaccines, diagnostic tools, and treatment modalities. R&D efforts focus on enhancing the efficacy, safety, and convenience of veterinary products, as well as developing novel therapies for animal health conditions. Companies collaborate with research institutions and veterinary experts to stay at the forefront of advancements in the field. Additionally, key players strive to expand their product portfolios by acquiring or licensing new products, technologies, or intellectual property rights. This allows them to offer a comprehensive range of veterinary medications, vaccines, diagnostics, nutritional supplements, and other healthcare products. Other than this, key players aim to penetrate new markets and expand their geographic presence to leverage untapped opportunities. This involves establishing partnerships, distribution agreements, or acquiring local companies to gain access to new customer bases and distribution networks. Besides this, key players in the market engage in collaborations and partnerships with veterinary clinics, hospitals, research institutions, and universities. These collaborations aim to drive product development, conduct clinical trials, and expand market reach. Moreover, they invest in marketing and promotional activities to create awareness about their products and services. They employ various channels, including digital marketing, conferences, veterinary events, and educational programs, to reach veterinarians, pet owners, and livestock farmers.
Archer-Daniels-Midland Company
Boehringer Ingelheim GmbH
Cargill Incorporated
Ceva Sante Animale
Dechra Pharmaceuticals PLC
Elanco Animal Health Incorporated
Evonik Industries AG
Merck & Co. Inc.
Neogen Corporation
Vetoquinol S.A.
Virbac
Zoetis Inc.
In April 2022, Elanco Animal Health Incorporated, a leading global animal health company, and Ginkgo Bioworks, the leading horizontal platform for cell programming, announced the launch of BiomEdit, a microbiome innovation company that is expected to discover, develop and introduce novel probiotics, bioactive molecules, engineered microbial medicines and microbial monitoring services for animal health..
Ceva Sante Animale, acquired Artemis Technologies Inc., this strategic move allows Ceva Sante Animale to enhance its portfolio of products dedicated to combating rabies in animals.
Archer-Daniels-Midland Company recently acquired a license for Gnubiotics AMOBIOME, a cutting-edge technology for use in pet food and supplement formulas. Gnubiotics AMOBIOME is a unique prebiotic that targets specific beneficial bacteria in the gut microbiome of animals.